Neffy Spray
Product Images NDC 71872-7330

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Neffy (NDC 71872-7330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7330.pdp (7330)

7330.pdp (7330)
Text panel for neffy (epinephrine nasal spray) 2 mg single-dose spray. Includes dosage form and strength, storage instructions, usage directions emphasizing single spray usage, manufacturer ARS Pharmaceuticals, repackager and distributor Medical Purchasing Solutions, and notes for reading the instructions for use.*
FDA Label Image

Figure 1 (Neffy 01)

Figure 1 (Neffy 01)
An instructional illustration showing how to administer two doses of nasal spray in the same nostril. The first image depicts a person positioning the spray for the first dose, while the second image shows the spray being tilted slightly upward for the second dose in the same nostril.*
FDA Label Image

Chemical Structure (Neffy 02)

Chemical Structure (Neffy 02)
Chemical structure diagram of epinephrine, showing the molecular arrangement of atoms and bonds characteristic of this active ingredient.*
FDA Label Image

Figure 2 (Neffy 03)

Figure 2 (Neffy 03)
A line graph depicting median pulse rate (PR) change from baseline in beats per minute (bpm) over 60 minutes for three forms of epinephrine: neffy 2 mg nasal spray, epinephrine 0.3 mg via needle-syringe, and epinephrine 0.3 mg via auto-injector. The graph shows PR changes over time in minutes on the x-axis and median PR change on the y-axis.*
FDA Label Image

Figure 2 (Neffy 04)

Figure 2 (Neffy 04)
A line graph comparing median systolic blood pressure (SBP) changes from baseline over 60 minutes among three treatments: neffy 2 mg nasal spray, epinephrine 0.3 mg via needle-syringe, and epinephrine 0.3 mg via auto-injector. The x-axis represents time in minutes, and the y-axis shows median SBP change in mmHg.*
FDA Label Image

Figure 3 (Neffy 05)

Figure 3 (Neffy 05)
A line graph showing median pulse rate change (bpm) over time (minutes) for neffy 2 mg and epinephrine 0.3 mg nasal sprays. Three curves compare neffy 2 mg twice right/left nostril with and without NAC, and epinephrine 0.3 mg thrice right/left nostril with NAC, illustrating pulse rate responses up to 60 minutes.*
FDA Label Image

Figure 3 (Neffy 06)

Figure 3 (Neffy 06)
A line graph showing median systolic blood pressure (SBP) change (mmHg) over time (minutes) for three treatments: neffy 2 mg administered twice in right/left nostrils (without NAC), neffy 2 mg twice in right/right nostrils (with NAC), and epinephrine 0.3 mg twice in right/left nostrils (with NAC). The graph compares the SBP response over a 60-minute period for these nasal spray treatments.*
FDA Label Image

Figure 4 (Neffy 07)

Figure 4 (Neffy 07)
A line graph comparing epinephrine plasma concentrations over 60 minutes for neffy 2 mg nasal spray and epinephrine 0.3 mg delivered by needle-syringe and auto-injector. The y-axis shows epinephrine plasma concentration in pg/mL, while the x-axis indicates time in minutes. Three curves with error bars illustrate differing absorption profiles for the three delivery methods.*
FDA Label Image

Figure 5a (Neffy 08)

Figure 5a (Neffy 08)
A line graph depicting epinephrine plasma concentration (pg/mL) over time (minutes) for different formulations: neffy 2 mg nasal spray with and without NAC, and epinephrine 0.3 mg and 0.5 mg delivered by needle-syringe injection. The graph compares the pharmacokinetic profiles of these treatments within a 60-minute timeframe.*
FDA Label Image

Figure 5b (Neffy 09)

Figure 5b (Neffy 09)
A line graph showing the geometric mean concentration (pg/mL) of neffy 2 mg nasal spray and epinephrine 0.3 mg over time (minutes) up to 60 minutes. The graph compares neffy given twice R/L with and without NAC, and epinephrine with NAC, depicting the changes in drug concentration levels in the bloodstream over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.